Keros Therapeutics Inc (KROS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | |||
| Net Income | -12,336 | N/A | N/A |
| Depreciation Amortization | 208 | N/A | N/A |
| Accounts payable and accrued liabilities | 1,312 | N/A | N/A |
| Other Working Capital | -6,724 | N/A | N/A |
| Other Operating Activity | 1,542 | 0 | 0 |
| Operating Cash Flow | $-15,998 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||
| PPE Investments | -271 | N/A | N/A |
| Investing Cash Flow | $-271 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||
| Common Stock Issued | 14 | N/A | N/A |
| Financing Cash Flow | $14 | $N/A | $N/A |
| Beginning Cash Position | 23,390 | N/A | N/A |
| End Cash Position | 7,135 | N/A | N/A |
| Net Cash Flow | $-16,255 | $N/A | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -15,998 | N/A | N/A |
| Capital Expenditure | -271 | N/A | N/A |
| Free Cash Flow | -16,269 | 0 | 0 |